All sites C00-96,D32-33,D42-43,D45-47,D76 15392 89.8 2.7 3.0 1.1 3.5
Mouth, pharynx C00-14 243 96.8 1.2 0.5 0.3 1.2
  Lip C00 29 98.6 - 0.7 0.7 -
  Tongue C02 57 98.6 - - 0.7 0.7
  Mouth, other C03-06 78 97.9 - 0.3 0.3 1.5
  Salivary glands C07-08 32 88.8 6.3 2.5 - 2.5
  Pharynx C01,C09-14 48 97.1 1.7 - - 1.3
Digestive organs C15-26 2771 80.9 2.9 7.8 2.2 6.1
  Oesophagus C15 88 93.4 0.2 1.6 2.5 2.3
  Stomach C16 266 93.7 0.6 1.5 1.3 2.9
  Small intestine C17 55 91.3 0.4 3.3 1.8 3.3
  Colon C18 957 94.8 0.2 1.9 0.6 2.4
  Rectum, rectosigmoid C19-20 428 96.7 - 1.0 0.7 1.5
  Anus C21 30 97.3 1.4 - 0.7 0.7
  Liver C22 170 69.9 4.2 15.1 3.2 7.6
  Gallbladder, bile ducts C23-24 154 58.6 8.6 14.6 3.5 14.7
  Pancreas C25 565 49.2 9.8 22.8 5.0 13.1
  Other digestive organs C26 59 38.9 2.7 17.4 10.2 30.7
Respiratory organs C30-39 921 68.6 13.4 9.2 2.5 6.2
  Nose, sinuses C30-31 17 96.5 - 1.2 1.2 1.2
  Larynx, epiglottis C32 14 97.1 - 1.4 - 1.4
  Lung, trachea C33-34 871 68.3 14.1 9.2 2.6 5.8
  Mediastinum, pleura C38 9 29.8 8.5 36.2 - 25.5
Bone C40-41 20 89.0 - 5.0 1.0 5.0
Melanoma of the skin C43 659 99.8 0.1 - - 0.1
Skin, non-melanoma C44 801 99.8 0.0 0.0 0.0 0.1
Mesothelioma C45 21 98.1 1.9 - - -
Autonomic nervous system C47 3 100.0 - - - -
Soft tissues C48-49 120 96.5 1.3 0.3 0.5 1.3
Breast C50 4826 99.3 0.2 0.1 0.1 0.3
Female genital organs C51-58 1685 94.4 1.7 1.4 0.8 1.7
  Cervix uteri C53 159 98.0 0.6 0.4 0.8 0.3
  Corpus uteri C54 830 99.0 0.1 0.3 0.2 0.5
  Uterus, other C55,C58 9 36.2 4.3 14.9 14.9 29.8
  Ovary C56 465 87.5 4.3 3.5 1.2 3.5
  Other female genital C51-52,C57 222 91.2 3.1 1.5 1.9 2.3
Urinary organs C64-68 674 89.6 1.0 4.0 1.2 4.1
  Kidney C64 396 86.9 0.6 5.8 1.7 5.0
  Bladder and urinary tract2 C65-68 277 93.6 1.6 1.4 0.6 2.7
Eye C69 14 72.1 2.9 7.4 11.8 5.9
Brain, central nervous system C70-72,D32-33,D42-43 577 88.5 - 5.0 0.8 5.8
Thyroid gland C73 348 97.0 2.2 0.2 0.2 0.4
Other endocrine glands C74-75 16 87.7 - 3.7 1.2 7.4
Illdefined or unknown C76,C80 351 53.2 11.5 14.4 5.5 15.5
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 1343 78.4 7.9 1.1 2.0 10.6
  Hodgkin lymphoma C81 64 99.4 0.3 - - 0.3
  Non-Hodgkin lymphoma C82-86,C96,D76 592 97.4 0.5 0.2 0.3 1.7
  Malignant immunoproliferative diseases C88 14 81.4 2.9 2.9 2.9 10.0
  Myeloma and other plasma cell tumors C90 191 64.0 10.1 5.1 4.5 16.3
  Leukaemia C91-95 284 62.6 18.9 0.6 2.9 15.0
  Myelodysplastic syndromes D46 64 27.5 17.5 1.3 3.4 50.3
  Myeloproliferaitive neoplasms D45,D47 134 62.8 13.9 0.4 4.5 18.4
Not included above
  Carcinoma in situ of the breast D05 394 99.9 - - - 0.1
  Cervix uteri, non-invasive neoplasms 998 100.0 - - - -
  Borderline tumour of the ovary D39 162 96.4 - 0.9 0.1 2.6
  Basal cell carcinoma of the skin 4579 100.0 - - 0.0 -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.